Richard Glynne

Verkställande Direktör på

Belharra Therapeutics, Inc.

Health Technology

Commercial Services

Finance

Profil

Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..

Aktiva positioner av Richard Glynne

Företag	Position	Start
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Privat kapitalinvesterare	2018-01-01
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Företagsledare/Principal	2018-11-01
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Verkställande Direktör	2025-01-01

Alla aktiva positioner av Richard Glynne

Tidigare kända positioner av Richard Glynne

Företag	Position	Slut
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Företagsledare/Principal	2018-11-01
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Privat kapitalinvesterare	2018-01-01
NOVARTIS AG	Privat kapitalinvesterare	2015-01-01
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Privat kapitalinvesterare	2004-01-01
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Företagsledare/Principal	2002-01-01

Se detaljerna i Richard Glynnes erfarenhet

Richard Glynnes utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Richard Glynnes erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	9
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Health Technology
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Finance
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Commercial Services
Imperial Cancer Research Fund Trading Ltd. Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Health Technology
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Distribution Services
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Commercial Services